APP and Alzheimer disease: In this study, we investigated the in vivo detection of Aβ oligomers using Shiga-Y51 by fluorine-19 (19F) magnetic resonance (MR) imaging (MRI) in an APP/PS1 double transgenic mouse model of AD.